Nasal Polyp
Patients with CRSwNP see smaller nasal polyps, less congestion with tezepelumab-ekko
Patients with severe chronic rhinosinusitis with nasal polyps experienced significant improvements in their symptoms with tezepelumab-ekko compared with placebo, according to a press release from Amgen and AstraZeneca.
Biologic use low among patients with chronic rhinosinusitis with nasal polyps
BOSTON — Patients with chronic rhinosinusitis with nasal polyps showed low biologics use and high discontinuation rates, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
FDA grants priority review to dupilumab for adolescents with CRSwNP
The FDA has accepted for priority review the supplemental biologics license application of dupilumab for adolescents with chronic rhinosinusitis with nasal polyps, Regeneron Pharmaceuticals Inc. and Sanofi announced in a press release.
Exhalation delivery system improves chronic rhinosinusitis symptoms
An exhalation delivery system that uses fluticasone reduced symptoms and improved quality of life for patients with chronic rhinosinusitis, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Charcot-Leyden crystals may predict nasal polyp recurrence after endoscopic sinus surgery
The presence of Charcot-Leyden crystals in nasal tissues may be used to predict the recurrence of eosinophilic chronic rhinosinusitis with nasal polyps, according to a letter published in Clinical and Translational Allergy.
Model uses clinical variables, biomarkers to accurately predict nasal polyp recurrence
A combined set of clinical and biological variables predicted polyp recurrence and severity among patients who have had endoscopic sinus surgery, according to a study published in The Journal of Allergy and Clinical Immunology.